Company Filing History:
Years Active: 2005
Title: Per-Olv Gunnarsson: Innovator in Chemotherapeutic Advancements
Introduction
Per-Olv Gunnarsson is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of oncology through his innovative approaches to chemotherapeutic treatments. His work focuses on enhancing the efficacy of established cancer therapies, particularly through intravenous administration methods.
Latest Patents
Gunnarsson holds a patent for "Methods to potentiate intravenous estramustine phosphate." Estramustine phosphate is an anti-mitotic chemotherapeutic drug known for its effectiveness against various cancers. His invention outlines methods that enhance the therapeutic benefits of this drug when administered intravenously at high dosages exceeding 1300 mg as a single dose. This approach significantly improves the pharmacokinetics of estramustine phosphate, making it more effective in treating a range of cancers, including prostate, breast, lung, colorectal, pancreatic, ovarian, and melanoma.
Career Highlights
Gunnarsson's career is marked by his dedication to advancing cancer treatment methodologies. He has worked with Pharmacia Italia S.p.a., where he has been able to apply his innovative ideas in a practical setting. His contributions have been instrumental in developing new treatment protocols that aim to improve patient outcomes.
Collaborations
Throughout his career, Gunnarsson has collaborated with esteemed colleagues, including Michael S. Kopreski and Beryl Asp. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking treatments.
Conclusion
Per-Olv Gunnarsson's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patent for enhancing the efficacy of estramustine phosphate represents a significant advancement in oncology. Through his career and collaborations, Gunnarsson continues to contribute to the fight against cancer, improving the lives of many patients.